Sign In
Buy BYSI
$1.74
+0.0400 (+2.35%)
At Close: Jun 03, 2026
Analysts Offer Insights on Healthcare Companies: Beyondspring (BYSI) and Portola Pharma (PTLA)
10:54am, Thursday, 19'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Beyondspring (BYSI) and Portola Pharma (PTLA) with bullish
Analysts Offer Insights on Healthcare Companies: Beyondspring (NASDAQ: BYSI) and Portola Pharma (NASDAQ: PTLA)
10:54am, Thursday, 19'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Beyondspring (
BYSI
–
Research Report
) and Portola Pharma (
PTLA
–
Research Report
) with bullish
Barclays PLC Has $267,000 Stock Position in Beyondspring Inc (NASDAQ:BYSI)
09:36am, Wednesday, 18'th Mar 2020
Barclays PLC increased its holdings in Beyondspring Inc (NASDAQ:BYSI) by 67.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. T
BeyondSpring Files for Patent Protection on BPI-002 for the Treatment of Viral Infections Including COVID-19
12:00pm, Wednesday, 11'th Mar 2020
BeyondSpring Inc. (the “Company” or “BeyondSpring”) (BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced the su
Short Interest in Beyondspring Inc (NASDAQ:BYSI) Declines By 5.2%
06:34am, Monday, 02'nd Mar 2020
Beyondspring Inc (NASDAQ:BYSI) saw a significant decline in short interest in the month of February. As of February 14th, there was short interest totalling 669,000 shares, a decline of 5.2% from the
Analysts have been eager to weigh in on the Healthcare sector with new ratings on VistaGen Therapeutics (VTGN), Beyondspring (BYSI) and Agenus (AGEN).
Analysts have been eager to weigh in on the Healthcare sector with new ratings on VistaGen Therapeutics (VTGN – Research
7 ‘Strong Buy’ Stocks With Over 50% Upside Potential
03:34pm, Tuesday, 18'th Feb 2020
No matter which strategy is employed or what types of stocks to buy are sought after, investors want to see returns.
BeyondSpring’s Plinabulin Stimulates Both the Adaptive and Innate Immune System in Cancer Patients
01:00pm, Monday, 10'th Feb 2020
BeyondSpring Inc. (the “Company” or “BeyondSpring”) (BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that n
Baird likes drug wholesalers in premarket analyst action
12:58pm, Friday, 07'th Feb 2020
Arcturus Therapeutics (NASDAQ:ARCT) initiated with Buy rating and $19 (70% upside) price target at Guggenheim.BeyondSpring (NASDAQ:BYSI) initiated with Buy rating and $25 (45% upside) price target at
Beyondspring (NASDAQ:BYSI) Rating Lowered to Hold at ValuEngine
08:30am, Thursday, 06'th Feb 2020
Beyondspring (NASDAQ:BYSI) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Tuesday, ValuEngine reports. Several other equities
BeyondSpring Appoints Pharma Veterans Drs. Daniel Zabrowski and Ramon Mohanlal to Company’s Board of Directors
01:00pm, Thursday, 23'rd Jan 2020
BeyondSpring Inc. (the “Company” or “BeyondSpring”) (BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced the ap
Beyondspring Inc (NASDAQ:BYSI) Expected to Announce Earnings of -$0.45 Per Share
11:52am, Monday, 20'th Jan 2020
Wall Street analysts predict that Beyondspring Inc (NASDAQ:BYSI) will report earnings of ($0.45) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates
Beyondspring (NASDAQ:BYSI) Coverage Initiated by Analysts at Nomura
01:00pm, Monday, 13'th Jan 2020
Nomura began coverage on shares of Beyondspring (NASDAQ:BYSI) in a research report released on Friday, Briefing.com Automated Import reports. The brokerage issued a buy rating and a $34.00 price targe
William Blair Reaffirms Buy Rating for Beyondspring (NASDAQ:BYSI)
11:30am, Monday, 13'th Jan 2020
William Blair reiterated their buy rating on shares of Beyondspring (NASDAQ:BYSI) in a report issued on Friday, AnalystRatings.com reports. BYSI has been the topic of several other reports. Nomura ini
